Evidence map›Paper›PMID 34876848›Full record

Trial reportJournal of pain research2021

Acupuncture versus Lornoxicam in the Treatment of Acute Renal Colic: A Randomized Controlled Trial.

Xiaohua Zhang, Xinguo Liu, Qiongxiang Ye, Xunbao Wang, Jinjun Chen, Zhiyong Wang, Pengfei Zhao, Baozhou Tao, Guoping Xu, Wanfeng Xu and 7 more

Open access · goldAbstract readCase ReportsClinical Trial
In one paragraph

Trial report in Journal of pain research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Efficacy and safety of acupuncture for pain relief: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Xiaohua Zhang *Institute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Nephro-Urological Clinical Center, Lanzhou, Gansu Province, People's Republic of China.
Xinguo Liu *Department of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Qiongxiang YeDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Xunbao WangDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Jinjun ChenDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Zhiyong WangDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Pengfei ZhaoDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Baozhou TaoDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Guoping XuDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Wanfeng XuDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Kan WuDepartment of Urology, Susong County People's Hospital, Susong, Anhui Province, People's Republic of China.
Yao XiaoDepartment of Pediatrics, Lanzhou University Second Hospital, Lanzhou, Gansu Province, People's Republic of China.
Li YangInstitute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Nephro-Urological Clinical Center, Lanzhou, Gansu Province, People's Republic of China.
Junqiang TianInstitute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Nephro-Urological Clinical Center, Lanzhou, Gansu Province, People's Republic of China.
Juan WangInstitute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Nephro-Urological Clinical Center, Lanzhou, Gansu Province, People's Republic of China.
Zhilong DongInstitute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Nephro-Urological Clinical Center, Lanzhou, Gansu Province, People's Republic of China.
Zhiping WangInstitute of Urology, Lanzhou University Second Hospital; Key Laboratory of Gansu Province for Urological Diseases; Gansu Nephro-Urological Clinical Center, Lanzhou, Gansu Province, People's Republic of China.ORCID 0000-0002-8140-591X
Lanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the analgesic efficacy and safety of acupuncture and lornoxicam in acute renal colic (ARC). DESIGN SETTING PARTICIPANT: A randomized, double-blind, parallel-controlled, single-centered trial was conducted at Susong County People's Hospital from October 2019 to November 2020. Eighty-four patients with ARC were randomly divided into lornoxicam group (Group L) and acupuncture group (Group A). Group A was treated with acupuncture at Sanyinjiao (SP6), Yinlingquan (SP9) and normal saline, and Group L was treated with sham acupuncture at SP6, SP9 and lornoxicam.

main outcome measuresVisual analogue scale (VAS) scores and adverse reactions such as nausea and dizziness were recorded within 5, 10, 15, 20 and 40 minutes after treatment. The main outcome of this study was the short-term effective (STE) rate, the secondary outcome was the onset time, and the safety index was incidence of adverse reactions.

resultsA total of 80 patients completed this study, including 41 patients (21 males and 20 females) in Group L and 39 patients (21 males and 18 females) in Group A. Group A exhibited lower scores versus group L after treatment (P < 0.05). The overall STE of group L was 61.00% (25/41), significantly lower than group A [84.62% (33/39)] (P < 0.001). There was no difference in the incidence of adverse reactions between group A [2.6% (1/39)] and group L [7.3% (3/41)] (P = 0.616). The ordered logistic regression analysis showed patients receiving acupuncture therapy are more likely to be cured [OR = 2.887, 95% CI: (1.190, 7.000), P = 0.019].

conclusionAcupuncture at SP6, SP9 and intramuscular injection of lornoxicam can effectively and safely relieve ARC, but the former has faster and better analgesic effect. Moreover, the incidence of adverse reactions was similar between the two treatments. This acupuncture therapy is recommended as a complementary therapy for ARC.

Indexed as

acupunctureanalgesialornoxicamrenal colic

Identifiers

PMID34876848
PMCPMC8643168
OpenAlexW3215799047

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.